A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: procedure (650), etiquette (1), practice (609)

Carboplatin (AUC4.5) Gemcitabine

Description
Chemotherapy Protocol BLADDER CARBOPLATIN (AUC4.5)-GEMCITABINE Regimen  Bladder-Carboplatin-Gemcitabine Indication  Locally advanced or metastatic urothelial cancer  WHO performance status
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Carboplatin-AUC4.5-Gemcitabine.pdf

Carboplatin-Etoposide

Description
Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6)-ETOPOSIDE (Intravenous / Oral) • SCLC – Carboplatin (AUC6)-Etoposide IV/PO Indication • First
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin-Etoposide-intravenous-and-oral.pdf

Carboplatin-Vinorelbine-IV-RT

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE-RADIOTHERAPY (Intravenous) Regimen • NSCLC – Carboplatin-Vinorelbine (intravenous)-Radiotherapy Indication • First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-IV-RT.pdf

Carboplatin and Vinorelbine (intravenous and oral)

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE (Intravenous and Oral) Regimen • NSCLC – Carboplatin-Vinorelbine (Intravenous and Oral) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/CarboplatinandVinorelbineintravenousandoral.pdf

CarboplatinAUC5 Etoposide IV/PO

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5)-ETOPOSIDE (Intravenous / Oral) Regimen • Ovary – Carboplatin (AUC5)-Etoposide IV/PO Indication • Small cell or neuroendocrine
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-EtoposideIVPO.pdf

Zanubrutinib Ver1

Description
Chemotherapy Protocol LYMPHOMA ZANUBRUTINIB Regimen • Lymphoma - Zanubrutinib Indication Zanubrutinib monotherapy for the treatment of patients with previously treated Waldenstrom’s macroglobulinaemia
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Zanubrutinib.pdf

Asciminib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Asciminib Regimen • Asciminib Indication • Patients with chronic phase Philadelphia chromosome-positive chronic myeloid Leukaemia previously treated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Asciminib.pdf

CarboplatinAUC4-Gemcitabine (1)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1) Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1) Indication • Recurrent platinum sensitive ovarian cancer
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabine1.pdf

Annual-report-2018-19

Description
ANNUAL REPORT AND ACCOUNTS 2018/19 incorporating the quality account 2018/19 Presented to Parliament pursuant to
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2018-19.pdf

Carboplatin (AUC5)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CARBOPLATIN (AUC 5) Regimen • Head and Neck – Carboplatin (AUC 5) Indication • Neoadjuvant (in combination with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Carboplatin-AUC5.pdf
341 to 350 of 698
Previous … 33 34 35 36 37 … Next